|
1
|
Fuchs E and Segre JA: Stem cells: A new
lease on life. Cell. 100:143–155. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gomperts BN and Strieter RM: Stem cells
and chronic lung disease. Annu Rev Med. 58:285–298. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rankin S: Mesenchymal stem cells. Thorax.
67:565–566. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Crystal RG, Randell SH, Engelhardt JF,
Voynow J and Sunday ME: Airway epithelial cells: Current concepts
and challenges. Proc Am Thorac Soc. 5:pp. 772–777. 2008; View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kajstura J, Rota M, Hall SR, Hosoda T,
D'Amario D, Sanada F, Zheng H, Ogórek B, Rondon-Clavo C,
Ferreira-Martins J, et al: Evidence for human lung stem cells. N
Engl J Med. 364:1795–1806. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rankin SM: Chemokines and adult bone
marrow stem cells. Immunol Lett. 145:47–54. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gupta N, Su X, Popov B, Lee JW, Serikov V
and Matthay MA: Intrapulmonary delivery of bone marrow-derived
mesenchymal stem cells improves survival and attenuates
endotoxin-induced acute lung injury in mice. J Immunol.
179:1855–1863. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Iyer SS and Rojas M: Anti-inflammatory
effects of mesenchymal stem cells: Novel concept for future
therapies. Expert Opin Biol Ther. 8:569–581. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Krampera M, Pasini A, Pizzolo G, Cosmi L,
Romagnani S and Annunziato F: Regenerative and immunomodulatory
potential of mesenchymal stem cells. Curr Opin Pharmacol.
6:435–441. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Weiss DJ, Kolls JK, Ortiz LA,
Panoskaltsis-Mortari A and Prockop DJ: Stem cells and cell
therapies in lung biology and lung diseases. Proc Am Thorac Soc.
5:pp. 637–667. 2008; View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Schuleri KH, Feigenbaum GS, Centola M,
Weiss ES, Zimmet JM, Turney J, Kellner J, Zviman MM, Hatzistergos
KE, Detrick B, et al: Autologous mesenchymal stem cells produce
reverse remodelling in chronic ischaemic cardiomyopathy. Eur Heart
J. 30:2722–2732. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Miyahara Y, Nagaya N, Kataoka M, Yanagawa
B, Tanaka K, Hao H, Ishino K, Ishida H, Shimizu T, Kangawa K, et
al: Monolayered mesenchymal stem cells repair scarred myocardium
after myocardial infarction. Nat Med. 12:459–465. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ishizawa K, Kubo H, Yamada M, Kobayashi S,
Numasaki M, Ueda S, Suzuki T and Sasaki H: Bone marrow-derived
cells contribute to lung regeneration after elastase-induced
pulmonary emphysema. FEBS Lett. 556:249–252. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Spees JL, Pociask DA, Sullivan DE, Whitney
MJ, Lasky JA, Prockop DJ and Brody AR: Engraftment of bone marrow
progenitor cells in a rat model of asbestos-induced pulmonary
fibrosis. Am J Respir Crit Care Med. 176:385–394. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tropea KA, Leder E, Aslam M, Lau AN,
Raiser DM, Lee JH, Balasubramaniam V, Fredenburgh LE, Alex
Mitsialis S, Kourembanas S, et al: Bronchioalveolar stem cells
increase after mesenchymal stromal cell treatment in a mouse model
of bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol.
302:L829–L837. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kim CF, Jackson EL, Woolfenden AE,
Lawrence S, Babar I, Vogel S, Crowley D, Bronson RT and Jacks T:
Identification of bronchioalveolar stem cells in normal lung and
lung cancer. Cell. 121:823–835. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jarvinen L, Badri L, Wettlaufer S, Ohtsuka
T, Standiford TJ, Toews GB, Pinsky DJ, Peters-Golden M and Lama VN:
Lung resident mesenchymal stem cells isolated from human lung
allografts inhibit T cell proliferation via a soluble mediator. J
Immunol. 181:4389–4396. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Toonkel RL, Hare JM, Matthay MA and
Glassberg MK; Potential for Clinical Testing, : Mesenchymal stem
cells and idiopathic pulmonary fibrosis. Potential for clinical
testing. Am J Respir Crit Care Med. 188:133–140. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tzouvelekis A, Paspaliaris V, Koliakos G,
Ntolios P, Bouros E, Oikonomou A, Zissimopoulos A, Boussios N,
Dardzinski B, Gritzalis D, et al: A prospective, non-randomized, no
placebo-controlled, phase Ib clinical trial to study the safety of
the adipose derived stromal cells-stromal vascular fraction in
idiopathic pulmonary fibrosis. J Transl Med. 11:1712013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chambers DC, Enever D, Ilic N, Sparks L,
Whitelaw K, Ayres J, Yerkovich ST, Khalil D, Atkinson KM and
Hopkins PM: A phase 1b study of placenta-derived mesenchymal
stromal cells in patients with idiopathic pulmonary fibrosis.
Respirology. 19:1013–1018. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Glassberg MK, Minkiewicz J, Toonkel RL,
Simonet ES, Rubio GA, DiFede D, Shafazand S, Khan A, Pujol MV,
LaRussa VF, et al: Allogeneic Human Mesenchymal Stem Cells in
Patients With Idiopathic Pulmonary Fibrosis via Intravenous
Delivery (AETHER): A Phase I Safety Clinical Trial. Chest.
151:971–981. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ranieri VM, Rubenfeld GD, Thompson BT,
Ferguson ND, Caldwell E, Fan E, Camporota L and Slutsky AS; ARDS
Definition Task Force, : Acute respiratory distress syndrome: The
Berlin Definition. JAMA. 307:2526–2533. 2012.PubMed/NCBI
|
|
23
|
Matthay MA, Ware LB and Zimmerman GA: The
acute respiratory distress syndrome. J Clin Invest. 122:2731–2740.
2012. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
McIntyre BA, Alev C, Mechael R, Salci KR,
Lee JB, Fiebig-Comyn A, Guezguez B, Wu Y, Sheng G and Bhatia M:
Expansive generation of functional airway epithelium from human
embryonic stem cells. Stem Cells Transl Med. 3:7–17. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hao Q, Zhu YG, Monsel A, Gennai S, Lee T,
Xu F and Lee JW: Study of Bone Marrow and Embryonic Stem
Cell-Derived Human Mesenchymal Stem Cells for Treatment of
Escherichia coli Endotoxin-Induced Acute Lung Injury in Mice. Stem
Cells Transl Med. 4:832–840. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Rafat N, Dacho C, Kowanetz G, Betzen C,
Tönshoff B, Yard B and Beck G: Bone marrow-derived progenitor cells
attenuate inflammation in lipopolysaccharide-induced acute
respiratory distress syndrome. BMC Res Notes. 7:6132014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yin X, Liang Z, Yun Y and Pei L:
Intravenous Transplantation of BMP2-Transduced Endothelial
Progenitor Cells Attenuates Lipopolysaccharide-Induced Acute Lung
Injury in Rats. Cell Physiol Biochem. 35:2149–2158. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wilson JG, Liu KD, Zhuo H, Caballero L,
McMillan M, Fang X, Cosgrove K, Vojnik R, Calfee CS, Lee JW, et al:
Mesenchymal stem (stromal) cells for treatment of ARDS: A phase 1
clinical trial. Lancet Respir Med. 3:24–32. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zheng G, Huang L, Tong H, Shu Q, Hu Y, Ge
M, Deng K, Zhang L, Zou B, Cheng B, et al: Treatment of acute
respiratory distress syndrome with allogeneic adipose-derived
mesenchymal stem cells: A randomized, placebo-controlled pilot
study. Respir Res. 15:392014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Shigemura N, Okumura M, Mizuno S, Imanishi
Y, Matsuyama A, Shiono H, Nakamura T and Sawa Y: Lung tissue
engineering technique with adipose stromal cells improves surgical
outcome for pulmonary emphysema. Am J Respir Crit Care Med.
174:1199–1205. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhen G, Xue Z, Zhao J, Gu N, Tang Z, Xu Y
and Zhang Z: Mesenchymal stem cell transplantation increases
expression of vascular endothelial growth factor in papain-induced
emphysematous lungs and inhibits apoptosis of lung cells.
Cytotherapy. 12:605–614. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Weiss DJ, Casaburi R, Flannery R,
LeRoux-Williams M and Tashkin DP: A placebo-controlled, randomized
trial of mesenchymal stem cells in COPD. Chest. 143:1590–1598.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Stolk J, Broekman W, Mauad T, Zwaginga JJ,
Roelofs H, Fibbe WE, Oostendorp J, Bajema I, Versteegh MI, Taube C,
et al: A phase I study for intravenous autologous mesenchymal
stromal cell administration to patients with severe emphysema. QJM.
109:331–336. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
U.S. National Library of Medicine, .
Safety Study of Bone-marrow Derived Mesenchymal Stromal Cells
Associated With Endobronchial Valves in Emphysema.
ClinicalTrials.gov Identifier: NCT01872624. https://clinicaltrials.gov/ct2/show/record/NCT01872624March
25–2015, pp. 3
|
|
35
|
ClinicalTrials.gov Identifier:
NCT01872624. Safety Study of Bone-marrow Derived Mesenchymal
Stromal Cells Associated With Endobronchial Valves in
Emphysema.
|
|
36
|
Ribeiro-Paes JT, Bilaqui A, Greco OT, Ruiz
MA, Marcelino MY, Stessuk T, de Faria C and Lago MR: Unicentric
study of cell therapy in chronic obstructive pulmonary
disease/pulmonary emphysema. Int J Chron Obstruct Pulmon Dis:.
6:63–71. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Baughman RPI, Culver DA, Jankovi V,
Fischkoff S, Brockway G and Lower EE: Placenta-derived
mesenchymal-like cells (PDA-001) as therapy for chronic pulmonary
sarcoidosis: A phase 1 study. Sarcoidosis Vasc Diffuse Lung Dis.
32:106–14. 2015.PubMed/NCBI
|
